Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Papain-like Protease Peptides as Construction Material for the SARS-CoV-2 Vaccine Design Candidate: In-silico Study

VALENSI · Vol. ume No. 1 (2025) · hlm. 138–149

DOI
10.15408/jkv.v11i1.42748
ISSN
2548-3013, 2460-6065
Terbit
2025-06-21
Penerbit
Department of Chemistry, Faculty of Science and Technology Syarif Hidayatullah Jakarta State Islamic University
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

COVID-19 remains a major global health threat. In addition to implementing health protocols and consuming supplements, proactive prevention strategies are essential to limit the spread of the virus. One of the most promising approaches is the use of vaccines, particularly peptide-based vaccines, which are under active development. This study aimed to design a peptide vaccine derived from the SARS-CoV-2 papain-like protease (PLpro) and evaluate its interaction with key components of the human immune system, namely Toll-like receptor 3 (TLR3), major histocompatibility complex class I (MHC-I), and class II (MHC-II). The research employed an immunoinformatics approach utilizing NetCTL, IEDB Tepitool, PEP-FOLD3, trRosetta, HDOCK, GalaxyRefine2, and other molecular modeling tools. The designed vaccine construct was visualized in 3D using trRosetta and validated through ERRAT2, achieving a 100% quality score, indicating excellent structural integrity. The docking simulations demonstrated stable interactions between the vaccine and the immune receptors, suggesting strong immunogenic potential. In conclusion, the in silico-designed peptide vaccine based on SARS-CoV-2 PLpro shows promise in triggering immune responses through stable binding with TLR3, MHC-I, and MHC-II, highlighting its potential as a candidate for further experimental validation in COVID-19 vaccine development.

Kata kunci

Jaringan kolaborasi para penulis

24 penulis · 69 tautan kepenulisan bersama · 34 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Bakti Tunas Husada
  • Universitas Perjuangan Tasikmalaya
  • National Nuclear Energy Agency of Indonesia
  • University of Malaya
  • Meteorological, Climatological, And Geophysical Agency
  • Padjadjaran University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Tresna LestariUniversitas Bakti Tunas Husada4
Anindita Tri Kusuma PratitaUniversitas Bakti Tunas Husada3
Tifa NofiantiUniversitas Bakti Tunas Husada2
Fajar SetiawanMeteorological, Climatological, And Geophysical Agency2
Nur RahayuningsihUniversitas Bakti Tunas Husada2
Nur Laili Dwi HidayatiUniversitas Bakti Tunas Husada2
Elsi EryantiUniversitas Bakti Tunas Husada2
Aas NuraisahAfiliasi tidak diketahui2
Gina Septiani AgustienUniversitas Perjuangan Tasikmalaya2
Delis SusilawatiUniversitas Perjuangan Tasikmalaya2
Sedin RenadiUniversitas Bakti Tunas Husada2
Gatut Ari WardaniUniversitas Bakti Tunas Husada2
Ade Dwi SeptianUniversitas Bakti Tunas Husada2
Zahra Putri HandiranaUniversitas Bakti Tunas Husada2
Veronika Yulianti SusiloNational Nuclear Energy Agency of Indonesia1
Isti DaruwatiNational Nuclear Energy Agency of Indonesia1
Febby PratamaUniversitas Bakti Tunas Husada1
Tita NofiantiUniversitas Bakti Tunas Husada1
Holis Abdul HolikPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://journal.uinjkt.ac.id/index.php/valensi/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Papain-like Protease Peptides as Construction Material for the SARS-CoV-2 Vaccine Design Candidate: In-silico Study</dc:title>
	<dc:creator xml:lang="en">Mardianingrum, Richa</dc:creator>
	<dc:creator xml:lang="en">Pertiwi, Nur Ihsani</dc:creator>
	<dc:creator xml:lang="en">Rizkuloh, Lina Rahmawati</dc:creator>
	<dc:creator xml:lang="en">Ikram, Nur Kusaira Khairul </dc:creator>
	<dc:creator xml:lang="en">Ruswanto, Ruswanto</dc:creator>
	<dc:subject xml:lang="en">Bioinformatics</dc:subject>
	<dc:subject xml:lang="en">COVID-19</dc:subject>
	<dc:subject xml:lang="en">immunoinformatic</dc:subject>
	<dc:subject xml:lang="en">papain-like protease</dc:subject>
	<dc:subject xml:lang="en">vaccine design</dc:subject>
	<dc:description xml:lang="en">COVID-19 remains a major global health threat. In addition to implementing health protocols and consuming supplements, proactive prevention strategies are essential to limit the spread of the virus. One of the most promising approaches is the use of vaccines, particularly peptide-based vaccines, which are under active development. This study aimed to design a peptide vaccine derived from the SARS-CoV-2 papain-like protease (PLpro) and evaluate its interaction with key components of the human immune system, namely Toll-like receptor 3 (TLR3), major histocompatibility complex class I (MHC-I), and class II (MHC-II). The research employed an immunoinformatics approach utilizing NetCTL, IEDB Tepitool, PEP-FOLD3, trRosetta, HDOCK, GalaxyRefine2, and other molecular modeling tools. The designed vaccine construct was visualized in 3D using trRosetta and validated through ERRAT2, achieving a 100% quality score, indicating excellent structural integrity. The docking simulations demonstrated stable interactions between the vaccine and the immune receptors, suggesting strong immunogenic potential. In conclusion, the in silico-designed peptide vaccine based on SARS-CoV-2 PLpro shows promise in triggering immune responses through stable binding with TLR3, MHC-I, and MHC-II, highlighting its potential as a candidate for further experimental validation in COVID-19 vaccine development.</dc:description>
	<dc:publisher xml:lang="en">Department of Chemistry, Faculty of Science and Technology Syarif Hidayatullah Jakarta State Islamic University</dc:publisher>
	<dc:date>2025-06-21</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uinjkt.ac.id/index.php/valensi/article/view/42748</dc:identifier>
	<dc:identifier>10.15408/jkv.v11i1.42748</dc:identifier>
	<dc:source xml:lang="en">Jurnal Kimia Valensi; Jurnal Kimia VALENSI,  Volume 11, No. 1, May 2025; 138-149</dc:source>
	<dc:source>2548-3013</dc:source>
	<dc:source>2460-6065</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uinjkt.ac.id/index.php/valensi/article/view/42748/17970</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Richa Mardianingrum, Nur Ihsani Pertiwi, Lina Rahmawati Rizkuloh, Ruswanto Ruswanto</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>